semaglutide hiv New research adds to the growing body of evidence around #Semaglutide. In a randomized, placebo-controlled trial, slowed multiple epigenetic markers of biological aging in adults living with HIV. $NVO #NovoNordisk #GLP1 # Semaglutide improves fatty liver disease

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) is reviewing data on the risk of suicidal thoughts and thoughts of self-harm with glucagon-like peptide-1 agonist (GLP-1a), including Ozempic (semaglutide), Saxenda (liraglutide) and Wegovy (semaglutide)

Learn more about this research format and the science behind it

Backed by breakthrough clinical studies, Retatrutide is rapidly becoming a leading candidate in obesity and metabolic disorder researchdemonstrating superior results to Semaglutide and Tirzepatide in early trials

The company plans more than 20 anti-obesity trials, including 10 Phase 3 studies targeted for 2026, as it builds out its obesity franchise

Achieve real results with MetroMed Healths personalized medical weight loss programs

Semaglutide belongs to a class of medications known as GLP-1 receptor agonists, which influence hormones involved in appetite regulation and metabolic signaling